Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Venter Retires as Chairman of Synthetic Genomics Board

J. Craig Venter has retired as chairman of the Synthetic Genomics board, according to a company news release.

Vista’s DJO Global Laying Off 187 Employees, Relocating to Texas

DJO Global, which grew from a garage startup to become one of North County’s largest private employers, is laying off 187 local employees and relocating its headquarters to Texas.

Local Device Cos. See Solid Quarterly Results

MEDICINE: National Picture Expecting 4% to 5% Growth

Four major medical device companies based in San Diego recently delivered strong quarterly results, lifting their stocks and growth outlooks.

Tease photo

La Jolla Institute Researcher Lands $2.24M Grant

Ferhat Ay with the La Jolla Institute for Allergy and Immunology was awarded a $2.24 million grant to for research into genetic variation and disease risk.

Rady’s Expands Services in Riverside with New Facility

Rady Children’s Hospital-San Diego recently held a grand opening for a medical plaza in southwest Riverside County, with the dual goal of consolidating outpatient operations and reaching more patients.

Partnerships, Pipeline Put Inovio in Good Position

PHARMA: Versatile Co. Takes On Cancers, Infectious Diseases

Inovio Pharmaceuticals Inc. has about 300 employees, tenfold that of 2009. Most of the scaling up occurred in the last few years to support a growing pipeline of therapies targeting cancers and infectious diseases.

Tease photo

Illumina Continues To Exceed Expectations

In quarter two earnings, Illumina continued a streak of stomping analyst expectations.

Tease photo

Walk-In Clinics Part Of Care Providers’ Pursuit of Patients

MEDICINE: Bringing Services to the Consumer Is Trend in Health Care

Forget far-off appointments and long drives to the doctor’s office.

Tease photo

Reporter’s Notebook: Politics and Priorities Hinder Repeal of Medical Device Tax

Competing congressional priorities are clouding the path forward for an effort to kill a 2.3 percent excise tax on medical device makers, San Diego’s NuVasive and ResMed among them.

Q2: Strong Ingrezza Sales Lift Neurocrine

Neurocrine’s Ingrezza — the first treatment for the nervous system disorder tardive dyskinesia — continues to rake in revenue.

More stories >>